| Aug 25 |
Wall Street Breakfast: The Week Ahead
|
| Aug 9 |
Sana Biotechnology rises 6% as data from several studies will be released by year-end
|
| Aug 8 |
Sana Biotechnology Non-GAAP EPS of -$0.32 misses by $0.08
|
| Aug 8 |
Sana: Q2 Earnings Snapshot
|
| Aug 8 |
Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates
|
| Aug 6 |
Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner
|
| Jul 14 |
Sana Biotechnology: Early-Stage Biotech With Promising Allogeneic CAR-T Pipeline
|
| May 21 |
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Gl...
|
